Cargando…
CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors
BACKGROUND: The receptor CXCR4 and its ligand CXCL12 play crucial roles in breast cancer. Despite the fact that the spontaneous feline mammary carcinoma (FMC) is considered a suitable model for breast cancer studies, the importance of the CXCR4/CXCL12 axis in FMC is completely unknown. Therefore, th...
Autores principales: | Marques, Cláudia S., Santos, Ana Rita, Gameiro, Andreia, Correia, Jorge, Ferreira, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048851/ https://www.ncbi.nlm.nih.gov/pubmed/30012106 http://dx.doi.org/10.1186/s12885-018-4650-9 |
Ejemplares similares
-
CXCL12-CXCR4 axis in feline mammary carcinoma
por: Ferreira, Fernando
Publicado: (2017) -
HER2-positive feline mammary carcinoma
por: Marques, Cláudia, et al.
Publicado: (2016) -
HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models
por: Gameiro, Andreia, et al.
Publicado: (2021) -
VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes
por: Gameiro, Andreia, et al.
Publicado: (2021) -
Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma
por: Gameiro, Andreia, et al.
Publicado: (2021)